Sign in
Back
Deeper virologic suppression with the addition of vebicorvir, a first-generation hepatitis B core inhibitor, to entecavir correlates with reduced inflammation and fibrosis-4 index in treatment naïve patients with HBeAg positive chronic hepatitis B
Journal article   Open access  Peer reviewed

Deeper virologic suppression with the addition of vebicorvir, a first-generation hepatitis B core inhibitor, to entecavir correlates with reduced inflammation and fibrosis-4 index in treatment naïve patients with HBeAg positive chronic hepatitis B

Mark S Sulkowski, Scott K Fung, Xiaoli Ma, Tuan T Nguyen, Eugene R. Schiff, Hie-Won L Hann, Douglas T Dieterich, Ronald G Nahass, James S Park, Sing Chan, …
Journal of hepatology, Vol.77, pp.S836-S837
2022-07
DOI: https://doi.org/10.1016/S0168-8278(22)01968-7
Appears in  Miller School of Medicine - Latest Publications
url
https://doi.org/10.1016/s0168-8278(22)01968-7View
Published (Version of record) Open

Metrics

1 Record Views

Details